Skip to main content

Table 3 Depression relation to medication taken by CVD patients, JUTH cardiac clinic, 2014–2015 (n = 284)

From: Determinates of depressive disorder among adult patients with cardiovascular disease at outpatient cardiac clinic Jimma University Teaching Hospital, South West Ethiopia: cross-sectional study

Characteristics

Total

N (%)

Nondepressed

N (%)

Depressed

N (%)

Medication

 Digoxin

62 (21.8)

33 (24.6)

29 (19.3)

 Diuretic

213 (75.0)

97 (72.4)

116 (77.3)

 Beta blocker

137 (45.2)

72 (53.7)

65 (43.3)

 Angiotensin-converting enzyme inhibitor

157 (55.3)

72 (53.7)

85 (56.7)

 Calcium channel blocker

24 (8.5)

9 (6.7)

15 (10.0)

 Anticoagulant

149 (52.5)

70 (52.2)

79 (52.7)

 Statine (lipid lowering agents)

22 (7.7)

11 (8.2)

11 (7.3)

 Penicillin

23 (8.1)

10 (7.5)

13 (8.7)

 Other?

17 (6.0)

8 (6.0

9 (6.0)

Duration of treatment (year)

 ≤ 1

91 (32.0)

50 (37.3)

41 (27.3)

 1–2

51 (18.0)

24 (17.9)

27 (18.0)

 2–3

29 (10.2)

12 (9.0)

17 (11.3)

 3–4

30 (10.6)

11 (8.2)

19 (12.7)

 ≥ 5

83 (29.2)

37 (27.6)

46 (30.7)

Medication adherence

 Non adherent

78 (27.5)

45 (30.0)

33 (24.6)

 Adherent

206 (72.5)

105 (70.0)

101 (75.4)

  1. Other medications—vasodilator, broncho-dilator, steroid, PTU, insulin, metformine, daonil, valsartan